ATXS - Astria Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATXS is currently covered by 4 analysts with an average price target of $28.75. This is a potential upside of $16.77 (139.98%) from yesterday's end of day stock price of $11.98.

Astria Therapeutics's activity chart (see below) currently has 46 price targets and 50 ratings on display. The stock rating distribution of ATXS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.02% with an average time for these price targets to be met of 237.86 days.

Highest price target for ATXS is $28, Lowest price target is $20, average price target is $25.5.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 16-Sep-2025. First documented stock forecast 13-Jan-2019.

Currently out of the existing stock ratings of ATXS, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$20

$11.69 (140.67%)

$16

1 months 1 days ago
(16-Sep-2025)

2/21 (9.52%)

$12.61 (170.64%)

255

Buy

$26

$17.69 (212.88%)

2 months 5 days ago
(12-Aug-2025)

0/3 (0%)

$19.13 (278.46%)

Buy

$28

$19.69 (236.94%)

$22

7 months 6 days ago
(11-Mar-2025)

1/9 (11.11%)

$20.86 (292.16%)

929

Buy

$28

$19.69 (236.94%)

$26

11 months 4 days ago
(13-Nov-2024)

1/8 (12.5%)

$17.91 (177.50%)

306

Buy

$36

$27.69 (333.21%)

3 years 11 months 6 days ago
(11-Nov-2021)

0/1 (0%)

$28.67 (391.13%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATXS (Astria Therapeutics) average time for price targets to be met?

On average it took 237.86 days on average for the stock forecasts to be realized with a an average price target met ratio 19.02

Which analyst has the current highest performing score on ATXS (Astria Therapeutics) with a proven track record?

LIANA MOUSSATOS

Which analyst has the current lower performing score on ATXS (Astria Therapeutics) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on ATXS (Astria Therapeutics)?

Liana Moussatos works at WEDBUSH and has 8 price targets and 7 ratings on ATXS

Which analyst is the currently most bullish on ATXS (Astria Therapeutics)?

Michael Higgins with highest potential upside - $27.69

Which analyst is the currently most reserved on ATXS (Astria Therapeutics)?

Liana Moussatos with lowest potential downside - $6.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?